Skip to main content
NOMD
NYSE Manufacturing

Nomad Foods Reports Q4 & FY25 Declines, Issues Negative FY26 Guidance; CEO Plans Open-Market Share Purchase

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
8
Price
$12
Mkt Cap
$1.808B
52W Low
$11.04
52W High
$20.81
Market data snapshot near publication time

Summary

Nomad Foods reported Q4 and full-year 2025 financial results with declines in key metrics and issued negative guidance for 2026, anticipating a 'transition year' as it implements strategic changes. The CEO expressed confidence and plans an open-market share purchase.


Key Events

  • Q4 & Full Year 2025 Financial Performance

    Reported revenue decreased 2.6% to €773 million in Q4 and 2.2% to €3.0 billion for the full year. Reported profit declined significantly due to €57 million in debt refinancing losses. Adjusted EBITDA decreased 4.7% in Q4 and 7.5% for the full year. Adjusted EPS increased 2.4% in Q4 but decreased 6.7% for the full year.

  • Negative FY26 Guidance Issued

    For fiscal year 2026, the company expects organic revenue to decline by 2%-5%, Adjusted EBITDA to decline by 5%-10%, and Adjusted EPS to be €1.45-€1.60, implying a 4-13% decline. Management describes 2026 as a 'transition year'.

  • CEO Plans Open-Market Share Purchase

    CEO Dominic Brisby stated his intent to make a 'sizable open-market purchase' of Nomad shares in the coming weeks to express confidence and align interests with shareholders, despite the anticipated transition year.

  • Shareholder Returns and Share Count Reduction

    The company returned €287 million to shareholders in 2025 through dividends and share repurchases, resulting in a 9% decrease in basic shares outstanding from year-end 2024.


Analysis

Nomad Foods reported a challenging fourth quarter and full year 2025, with declines in reported revenue, profit, and Adjusted EBITDA. While Q4 Adjusted EPS saw a modest increase, full-year Adjusted EPS decreased. The company's 2026 guidance projects further declines in organic revenue, Adjusted EBITDA, and Adjusted EPS, signaling a 'transition year' as management implements foundational changes. A significant one-time loss of €57 million from debt refinancing impacted reported profit and EPS in Q4 and the full year. Despite the negative financial outlook, the CEO's stated intent to make a sizable open-market purchase of shares in the coming weeks provides a potential vote of confidence, aligning management's interests with shareholders during this period of strategic overhaul.

At the time of this filing, NOMD was trading at $12.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $11.04 to $20.81. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NOMD - Latest Insights

NOMD
May 18, 2026, 4:27 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $10.24
Real-time Price: $10.43 info
Change: +$0.190 (+2%) info
Market Cap: $1.458B info
NOMD
May 13, 2026, 5:03 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $9.20
Real-time Price: $10.43 info
Change: +$1.23 (+13%) info
Market Cap: $1.458B info
NOMD
May 13, 2026, 6:45 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $9.52
Real-time Price: $10.43 info
Change: +$0.910 (+10%) info
Market Cap: $1.458B info
NOMD
May 08, 2026, 7:54 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $10.14
Real-time Price: $10.43 info
Change: +$0.290 (+3%) info
Market Cap: $1.458B info
NOMD
May 07, 2026, 6:45 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $10.24
Real-time Price: $10.43 info
Change: +$0.190 (+2%) info
Market Cap: $1.458B info
NOMD
Mar 12, 2026, 5:58 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $9.61
Real-time Price: $10.43 info
Change: +$0.820 (+9%) info
Market Cap: $1.458B info
NOMD
Mar 05, 2026, 4:31 PM EST
Filing Type: F-3ASR
Importance Score:
8
Price at Filing: $10.25
Real-time Price: $10.43 info
Change: +$0.180 (+2%) info
Market Cap: $1.458B info
NOMD
Feb 26, 2026, 8:53 AM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $10.99
Real-time Price: $10.43 info
Change: -$0.560 (-5%) info
Market Cap: $1.458B info
NOMD
Feb 26, 2026, 6:47 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $12.00
Real-time Price: $10.43 info
Change: -$1.57 (-13%) info
Market Cap: $1.458B info
NOMD
Feb 26, 2026, 6:46 AM EST
Filing Type: 20-F
Importance Score:
8
Price at Filing: $12.00
Real-time Price: $10.43 info
Change: -$1.57 (-13%) info
Market Cap: $1.458B info